BSE Code :
NSE Symbol :
ISIN :
Industry :

Trade Now

Get Quotes

Open Price (₹)

Prev. Close (₹)

Volume (No’s)

Market Cap (₹)

Low Price (₹)

High Price (₹)

Chart

Technical Chart

Corparate Information

Financials

Corporate Action

Board Meetings

Start Date	End Date	Purpose
13-Mar-2020	01-Apr-2020	Pursuant to Reg 30(7) of SEBI LODR, further to our communication dated Feb 26, 2020, plS see enclosed a copy of the order dated Feb 26, 2020 and clarification dated Feb 28, 2020 alongwith order as per Form CAA 7 issued by the Hon''ble (NCLT), Chandigarh Bench on March 12, 2020 in respect of the scheme of amalgamation amongst GlaxoSmithKline Consumer Healthcare Limited and HUL and their respective shareholders and creditors under Section 230 to 232 of the Companies Act, 2013 ('Scheme'). In this regard, we wish to inform you that in accordance with the terms of the Scheme, a meeting of Board of Director of the Company is scheduled to be held on Wednesday, April 01, 2020, to take on record the sanction of the Scheme by Hon'ble NCLT Mumbai Bench and Chandigarh Bench and to declare the scheme effective. Further, it is to inform you that at this BM will consider the record date for the purpose of issuance of shares of HUL to the shareholders of the Company in accordance with the Scheme.
13-Jan-2020	06-Feb-2020	GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2020 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, Notice is hereby given that a meeting of the Board of Directors will be held on Thursday, February 06, 2020 at the Corporate Office of the Company situated at 24th & 25th Floor, One Horizon Center, DLF Phase - V, Golf Course Road, Gurugram 122002 to, inter alia, to consider and take on record the Unaudited Financial Results for the Third Quarter ended December 31, 2019 with Limited Review by Auditors. We request you to take the above information on record. Pursuant to Regulation 33 and 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 we would like to inform you that the Board of Directors in its meeting Thursday, February 06, 2020 at 01:30 p.m. at Board Room, One Horizon Centre, DLF Phase - V, Golf Course Road, Gurugram 122002 have, inter alia, considered and taken on record the Unaudited Financial Results for the Quarter ended December 31, 2019. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, we wish to inform you that Mr. Vivek Anand resigned as Chief Financial Officer w.e.f. October 31, 2019 and Mr. Nitin Mathur joined as Head of Finance w.e.f. November 01, 2019. We are enclosing a copy of the Unaudited Financial Results for the Quarter ended December 31, 2019 along with the 'Limited Review' Report, issued by the Auditors for the review done by them, for your records. (As Per BSE Announcement dated on 06/02/2020)
14-Oct-2019	07-Nov-2019	GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2019 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, Notice is hereby given that a meeting of the Board of Directors will be held on Thursday, November 07, 2019 at the Corporate Office of the Company situated at 24th & 25th Floor, One Horizon Center, DLF Phase - V, Golf Course Road, Gurugram 122002 to, inter alia, to consider and take on record the Unaudited Financial Results for the Second Quarter ended September 30, 2019 with Limited Review by Auditors. We request you to take the above information on record.
27-Jun-2019	01-Aug-2019	GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI {Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Thursday, August 1, 2019 at Conference Room, GlaxoSmithKline Consumer Healthcare Limited, Patiala Road, Nabha -147201 to, inter-alia, consider and take on record the unaudited Financial Results for the quarter ended June 30, 2019 with Limited Review by Auditors. Pursuant to Regulation 33 and 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 we would like to inform you that the Board of Directors in its meeting held on Thursday, August 01, 2019 at Conference Room, GlaxoSmithKline Consumer Healthcare Limited, Patiala Road, Nabha 147201 (Punjab) have, inter alia, considered and taken on record the Unaudited Financial Results for the quarter ended June 30, 2019. We are enclosing a copy of the Unaudited Financial Results for the quarter ended June 30, 2019 along with the 'Limited Review' Report, issued by the Auditors for the review done by them, for your records. (As Per BSE Announcement Dated 01.08.2019)
02-May-2019	10-May-2019	GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that a meeting of the Board of Directors will be held on May10, 2019, inter alia, to consider and take on record the Audited Financial Results for the Financial Year ended March 31, 2019 and to consider dividend for the Financial Year ended March 31, 2019. GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2019 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, Notice is hereby given that a meeting of the Board of Directors will be held on Friday, May 10, 2019 at the Corporate Office of the Company situated at 24th & 25th Floor, One Horizon Center, DLF Phase - V, Golf Course Road, Gurugram 122002 to, inter alia, to consider and take on record the Audited Financial Results for the Financial Year ended March 31, 2019 and to consider dividend for the Financial Year ended March 31, 2019. We request you to take the above information on record. The Register of Members and Share Transfer Books will remain closed from Saturday, July 27, 2019 to Friday, August 2, 2019, both days inclusive for the purpose of Dividend and Annual General Meeting. The Board also recommended a Dividend at the rate of Rs. 105/- per equity share of Rs. 10 each. The Dividend, if approved by the shareholders in the ensuing Annual General Meeting scheduled to be held on Friday, August 2, 2019, will be paid to those members whose names appear in the Company's Register of Members and to those persons whose names appear as Beneficial owners as per the details to be furnished by National Securities Depository Limited and Central Depository Services (India) Ltd. as at the close of business hours on Friday, July 26, 2019. The 60th Annual General Meeting of the members of the Company will be held on Friday, August 2, 2019 at 9.30 a.m. at Punjab Public School Auditorium, The Punjab Public School (Senior Wing), Nabha 147 201 (Punjab In accordance with SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015, please note that the Board of Directors of the Company at its meeting held on May 10, 2019, had approved the Audited Financial results for the year ended March 31, 2019, a copy of which is enclosed for your reference and records. Deloitte Haskins & Sells LLP, Statutory Auditors of the Company, has issued an Audit Report with Unmodified opinion on Audited Financial Results of the Company (Standalone and Consolidated) for the quarter and year ended March 31, 2019. The aforesaid declaration is given pursuant to Regulation 33(3)(d) and 52(3)(a) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 as amended and Circular no. CIR/CFD/CMD/56/2016 dated May 27,2016. The Board also recommended a Dividend at the rate of Rs. 105/- per equity share of Rs. 10 each. The Register of Members and Share Transfer Books will remain closed from Saturday, July 27, 2019 to Friday, August 2, 2019, both days inclusive for the purpose of Dividend and Annual General Meeting. The 60th Annual General Meeting of the members of the Company will be held on Friday, August 2, 2019 at 9.30 a.m. at Punjab Public School Auditorium, The Punjab Public School (Senior Wing), Nabha 147 201 (Punjab Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on May 10, 2019 had appointed Mr. P.V. Bhide (DIN :03304262) as an Additional and Independent Director, with effect from May 10, 2019 till the ensuing Annual General Meeting. (As Per BSE Announcement Dated on 10.05.2019) GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 10, 2019, inter alia, has recommended a Dividend at the rate of Rs. 105/- per equity share of Rs. 10 each. GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 27, 2019 to August 02, 2019 (both days inclusive) for the purpose of Payment of Dividend & 60th Annual General Meeting (AGM) of the Company to be held on August 02, 2019. The dividend shall be paid to the entitled Members on or before September 01, 2019. (As Per BSE Announcement Dated On 11/05/2019)